Cargando…
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-...
Autores principales: | Huang, Zhen, Tian, Di, Liu, Yang, Lin, Zhen, Lyon, Christopher J., Lai, Weihua, Fusco, Dahlene, Drouin, Arnaud, Yin, Xiaoming, Hu, Tony, Ning, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245202/ https://www.ncbi.nlm.nih.gov/pubmed/32553350 http://dx.doi.org/10.1016/j.bios.2020.112316 |
Ejemplares similares
-
Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality
por: Dumonteil, Eric, et al.
Publicado: (2021) -
CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications
por: Huang, Zhen, et al.
Publicado: (2023) -
Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
por: Nave, Stephane, et al.
Publicado: (2017) -
Escalation of liPid-lOwering therapy in patientS wiTh vascular disease receiving HIGH-intensity statins: the retrospective POST-HIGH study
por: Ha, Jaehyung, et al.
Publicado: (2021) -
CRISPR-based assays for low-resource settings
por: Huang, Zhen, et al.
Publicado: (2023)